Genmab A/SGMABNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-44.7%
5Y CAGR-32.9%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-44.7%/yr
vs +154.2%/yr prior
5Y CAGR
-32.9%/yr
Recent deceleration
Acceleration
-199.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 18.95% |
| 2024 | 25.97% |
| 2023 | -15.09% |
| 2022 | 112.22% |
| 2021 | -53.22% |
| 2020 | 139.31% |
| 2019 | 91.12% |
| 2018 | 2.69% |
| 2017 | 27.67% |
| 2016 | 44.15% |